Jiedu Huayu Oral Prescription in the Treatment of Intracranial Hemorrhage Associated With Cerebral Amyloid Angiopathy

Abroad (travel likely)RecruitingPHASE3

Conditions

Cerebral Amyloid Angiopathy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Contact: Study coordinator (Dr.) · shuxianlyu@163.com · 010-5997-5835

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy

Cerebral Amyloid Angiopathy

Abroad (travel likely)RecruitingPHASE2

Los Angeles, United States · Orange, United States

Colchicine for the Prevention of Recurrence in Cerebral Amyloid Angiopathy RElated IntraCerebral Hemorrhage

Cerebral Amyloid Angiopathy · Intracerebral Hemorrhage Lobar

Abroad (travel likely)RecruitingPHASE2

Beijing, China · Chengdu, China

SEarchiNg biomarkErs Cerebral Amyloid Angiopathy (SENECA)

Cerebral Amyloid Angiopathy

Abroad (travel likely)Recruiting

Milan, Italy

Application of Digital Twins' Technology in Patients Who Had a Stroke, With Moyamoya Disease and With Cerebral Amyloid Angiopathy (CAA) During the Secondary Prevention Phase: A Proof of Concept Using a Randomized Control Trial (Clinical Study 6, STRATIF-AI Project)

Stroke · Moyamoya Disease · Cerebral Amyloid Angiopathy

Abroad (travel likely)Recruiting

Milan, Italy